Human monoclonal antibody development
Ended Purchase Order Awarded Last action
- Contract number
- HT942524P0103
- Awardee
-
Genovac Antibody Discovery LLC UEI XLZUCKG5TEJ5
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $120,000
Award facts
- Opportunity
-
- Human Monoclonal Antibody (mAb) Development for Walter Reed Army Institute of Research (WRAIR), Armed Forces Research Institute of Medical Sciences (WRAIR-AFRIMS) Pre-Solicitation · HT942524Q0057 · Posted Mar 26, 2024
- Contract value 67% obligated
-
- $120,000.00 Current, with exercised options
- $180,000.00 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Silver Spring, MD 20910, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Funding Only Action | $40,000 | |
| Change Order | -$40,000 | |
| Original award | $120,000 |
About this award
The Defense Health Agency awarded a $180,000 purchase order to Genovac Antibody Discovery LLC on September 6, 2024 for human monoclonal antibody development, with performance concluding June 24, 2026. Work is performed in Silver Spring, Maryland. The effort supports the Walter Reed Army Institute of Research and Armed Forces Research Institute of Medical Sciences, encompassing feasibility studies for development and production of fully human monoclonal antibodies using supplied target antigens or cultured B cells, including immunizing transgenic animal models, high-throughput screening, cloning and expressing recombinant antibodies, and shipping materials for testing. This purchase order originated from a pre-solicitation request for information posted March 26, 2024.
Quick answers
Who was awarded contract HT942524P0103?
HT942524P0103 was awarded to Genovac Antibody Discovery LLC by Defense Health Agency (Department of Defense) on September 6, 2024.
How much is contract HT942524P0103 worth?
The government has obligated $120,000 on HT942524P0103. Its potential value, with all options, is $180,000.
Was contract HT942524P0103 competed?
The extent of competition for HT942524P0103 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award